SEC Filings

Form S-3
SELECTA BIOSCIENCES INC filed this Form S-3 on 08/11/2017
Document Outline
Entire Document (1371.2 KB)
Subdocument 1 - S-3 - S-3
Page 1 - As filed with the Securities and Exchange Commission on August 11, 2017
Page 2 - EXPLANATORY NOTE
Page 3 - The information in this prospectus is not complete and may be changed. These securities may not be s
Page 4 - TABLE OF CONTENTS
Page 5 - ABOUT THIS PROSPECTUS
Page 6 - WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
Page 7 - N/A
Page 8 - THE COMPANY
Page 9 - RISK FACTORS
Page 10 - USE OF PROCEEDS
Page 11 - RATIOS OF EARNINGS TO FIXED CHARGES AND RATIOS OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED S
Page 12 - DESCRIPTION OF CAPITAL STOCK
Page 13 - Preferred Stock
Page 14 - Termination of Registration Rights
Page 15 - Removal of Directors.
Page 16 - DESCRIPTION OF DEBT SECURITIES
Page 17 - N/A
Page 18 - Transfer and Exchange
Page 19 - Consolidation, Merger and Sale of Assets
Page 20 - Modification and Waiver
Page 21 - N/A
Page 22 - Defeasance of Debt Securities and Certain Covenants in Certain Circumstances
Page 23 - No Personal Liability of Directors, Officers, Employees or Stockholders
Page 24 - DESCRIPTION OF WARRANTS
Page 25 - N/A
Page 26 - DESCRIPTION OF UNITS
Page 27 - GLOBAL SECURITIES
Page 28 - N/A
Page 29 - N/A
Page 30 - PLAN OF DISTRIBUTION
Page 31 - N/A
Page 32 - LEGAL MATTERS
Page 33 - The information in this preliminary prospectus supplement is not complete and may be changed. These
Page 34 - TABLE OF CONTENTS
Page 35 - ABOUT THIS PROSPECTUS SUPPLEMENT
Page 36 - WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
Page 37 - Selecta Biosciences, Inc.
Page 38 - THE COMPANY
Page 39 - THE OFFERING
Page 40 - RISK FACTORS
Page 41 - CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 42 - USE OF PROCEEDS
Page 43 - DILUTION
Page 44 - PLAN OF DISTRIBUTION
Page 45 - LEGAL MATTERS
Page 46 - Common Stock
Page 47 - PART II
Page 48 - Item 16.
Page 49 - provided
Page 50 - bona fide
Page 51 - SIGNATURES
Page 52 - N/A
Page 53 - EXHIBIT INDEX
Subdocument 2 - EX-1.2 - EX-1.2
Page 1 - Exhibit 1.2
Page 2 - Company
Page 3 - Maximum Program Amount
Page 4 - Selling Period
Page 5 - Prospectus
Page 6 - Section 6
Page 7 - Exchange Act Compliance
Page 8 - Authorization of the Shares
Page 9 - Material Adverse Effect
Page 10 - FINRA
Page 11 - Regulatory Compliance
Page 12 - Stock Plan
Page 13 - Investment Company Act
Page 14 - USPTO
Page 15 - Environmental Laws
Page 16 - Internal Controls
Page 17 - Sanctions
Page 18 - HIPAA
Page 19 - Stock Exchange Listing
Page 20 - Section 3.
Page 21 - Time of Sale
Page 22 - Fees
Page 23 - Interim Prospectus Supplement )
Page 24 - Agent s Review of Proposed Amendments and Supplements
Page 25 - Filing of Agent Free Writing Prospectuses
Page 26 - Earnings Statement
Page 27 - Triggering Event Date
Page 28 - provided, however
Page 29 - Rule 102
Page 30 - Section 4(m)
Page 31 - No Misstatement or Material Omission
Page 32 - Indemnification of the Company, its Directors and Officers
Page 33 - Section 6
Page 34 - provided, however
Page 35 - Section 7.
Page 36 - Research Analyst Independence
Page 37 - Section 8(d)
Page 38 - [Signature Page Immediately Follows]
Page 39 - N/A
Page 40 - EXHIBIT A
Subdocument 3 - EX-4.2 - EX-4.2
Page 1 - Exhibit 4.2
Page 2 - TABLE OF CONTENTS
Page 3 - N/A
Page 4 - N/A
Page 5 - SELECTA BIOSCIENCES, INC.
Page 6 - Company
Page 7 - Corporate Trust Office
Page 8 - Indenture
Page 9 - TIA
Page 10 - Incorporation by Reference of Trust Indenture Act
Page 11 - Establishment of Terms of Series of Securities
Page 12 - N/A
Page 13 - Execution and Authentication
Page 14 - Registrar and Paying Agent
Page 15 - Paying Agent
Page 16 - Mutilated, Destroyed, Lost and Stolen Securities
Page 17 - Outstanding Securities
Page 18 - Cancellation
Page 19 - Legends
Page 20 - CUSIP Numbers
Page 21 - Notice of Redemption
Page 22 - Deposit of Redemption Price
Page 23 - Compliance Certificate
Page 24 - Successor Corporation Substituted
Page 25 - Bankruptcy Law
Page 26 - ipso facto
Page 27 - Trustee May File Proofs of Claim
Page 28 - Application of Money Collected.
Page 29 - Unconditional Right of Holders to Receive Principal and Interest
Page 30 - Waiver of Past Defaults
Page 31 - Duties of Trustee
Page 32 - Rights of Trustee
Page 33 - Individual Rights of Trustee
Page 34 - Reports by Trustee to Holders
Page 35 - Replacement of Trustee
Page 36 - Successor Trustee by Merger, Etc
Page 37 - Application of Trust Funds; Indemnification
Page 38 - Legal Defeasance of Securities of any Series
Page 39 - Covenant Defeasance
Page 40 - Repayment to Company
Page 41 - Reinstatement
Page 42 - With Consent of Holders
Page 43 - Compliance with Trust Indenture Act
Page 44 - Trustee Protected
Page 45 - Communication by Holders with Other Holders
Page 46 - Statements Required in Certificate or Opinion
Page 47 - Governing Law; Waiver of Jury Trial; Consent to Jurisdiction
Page 48 - Severability
Page 49 - New York Banking Day
Page 50 - optional sinking fund payment
Page 51 - N/A
Page 52 - IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of the day
Subdocument 4 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - Documents
Subdocument 5 - EX-5.2 - EX-5.2
Page 1 - Exhibit 5.2
Subdocument 6 - EX-12.1 - EX-12.1
Page 1 - Exhibit 12.1
Subdocument 7 - EX-23.3 - EX-23.3
Page 1 - Exhibit 23.3
Back to Top